Comprehensive clinical genotyping services provided with market-leading speed enable researchers and clinicians to make decisions faster. Get prospective IVDR-compliant Sanger sequencing results in just 3 days to optimize patient selection and management for clinical trials or get extensive retrospective next-generation sequencing (NGS) data within 2 weeks to access critical data for biomedical research.
Simple workflow with automated operations
High-throughput NGS is available as orthogonal method for HLA-A testing to resolve potential ambiguities of genotyping results with NGSgo® MX6-1 Assay and NGSengine® software from GenDx. Discovery’s advanced NGS technologies, including Illumina NovaSeq X Plus systems, optimized protocols, automated workflows, strict regulatory compliance, and industry-leading expertise, deliver reliable data at any scale.
ThermoFisher 3500 Dx Genetic Analyzer
Join Discovery Life Sciences at Phacilitate's Advanced Therapies Week 2025, Jan 20-23 in Dallas! Visit us at Booth 161 and join Dr. Yuki Maves' presentation on Jan 23. Supply Chain: Future of Apheresis & Collections Location: Theater 5 Date/Time: Jan 23, Time TBD
Join Discovery at Precision Medicine Tri-Con 2025.
Join Discovery at World CB & CDx Summit Europe 2025.
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
